creatine monohydrate 1000 (marca mrm) polvo para solucion oral
super alimentos deportivos sociedad comercial de responsabilidad limitada - polvo para solucion oral
creatine monohydrate 100% polvo oral
natural nutrition s.a.c. - polvo oral
creatine monohydrate 325 (narca mrm) polvo para solucion oral
super alimentos deportivos sociedad comercial de responsabilidad limitada - polvo para solucion oral
creatine monohydrate polvo oral
transformax s.a.c. - polvo oral
pro performance creatine monohydrate orange tableta
drogueria la victoria s.a.c. - tableta
100 % pure creatine monohydrate vitamin shoppe cápsulas
vitamin shoppe global, inc. - cápsulas
creatine monohydrate bodytech 5 g polvo oral
vitamin shoppe global, llc. - polvo oral
gnc creatine monohydrate 3500 cápsulas
general nutrition corporation - cápsulas
creatine monohydrate . polvo para solucion oral
versus peru s.a.c. - droguerÍa - polvo para solucion oral - por gramo - - productos varios para el tracto alimentario y el metabolismo
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.